EMA recommends approval of bevacizumab biosimilar Vegzelma

Biosimilars/News | Posted 01/07/2022 comments 0
Bevacizumab 1 V14f01

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 24 June 2022 that it had recommended granting marketing authorization for the bevacizumab bi...

More >
FORO LATINOAMERICANO DE ESTA SEMANA
Naming 3 V13J04
Nomenclature of biologicals and biocomparables in Mexico
Posted 18/03/2022

Following the articles on the management and implementation of the nomenclature of biol...

25 AA011049
COVID-19 vaccine produced in Latin America
Posted 18/03/2022

The World Health Organization (WHO) approved a COVID-19 vaccine produced in Latin Ameri...

INVIMA V22B11
Biosimilars approved in Colombia
Posted 11/02/2022

In Colombia, the regulatory body for the approval of biologicals is the National Food a...

Home/Non‐Biological Complex Drugs
Liposome V15L11

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft guidance...

More >